Table 11.
| Priority of clinical issue | Target population | Interventions |
|---|---|---|
| Vascular protection | All people with diabetes | ACE inhibitor (as indicated) |
| Antiplatelet therapy (80–325 mg/d ASA) | ||
| Blood pressure control | ||
| Glycemic control | ||
| Lifestyle modification: nutrition therapy, | ||
| regular physical activity, weight management | ||
| Lipids control | ||
| Smoking cessation |